Skip to content
The Policy VaultThe Policy Vault

Nexavar (sorafenib) — Medica

Soft tissue sarcoma

Initial criteria

  • age ≥ 18 years
  • diagnosis of angiosarcoma OR desmoid tumors (aggressive fibromatosis) OR solitary fibrous tumor/hemangiopericytoma

Approval duration

1 year